Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-25 @ 2:56 AM
NCT ID:
NCT00376233
Eligibility Criteria:
Inclusion Criteria:
Patients:
* acutely ill
* consecutively admitted
* diagnosis of schizophrenia according to DSM-IV criteria for paranoide schizophrenia.
* not treated or treated with atypical neuroleptic drugs
* cannabis use on a regular basis (≥ 0,5 g/d, at least 3 month) prior to admission or
* never use of cannabis apart from unique trials
* no use of any other drug or alcohol on a regular basis.
Controls:
* healthy volunteers recruited by newspaper advertisement
* cannabis user (duration and dose of cannabis use as in patients)or
* no cannabis experience at all
All cannabis consuming participants:
* positive for cannabinoids in urine test at the time of niacin testing
Exclusion Criteria:
Controls:
* current psychiatric diagnosis or psychiatric personal or family history.
All individuals:
* any current or history of skin disorders (eczema, atopical dermatitis, psoriasis)
* recent treatment with steroids or non-steroidal antiinflammatory drugs (e.g. acetylsalicylic acid)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT00376233
Study Brief:
Protocol Section:
NCT00376233